Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 6/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4389584 | 0.86 | CYP3A4 (0.60) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL289898 | 0.86 | CYP1A2 (0.56) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL11193599 | 0.84 | CYP1A2 (0.50) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL27536605 | 0.81 | CYP1A2 (0.64) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL24239786 | 0.79 | CYP3A4 (0.53) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL3289319 | 0.79 | CYP3A4 (0.62) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL6264784 | 0.79 | CYP3A4 (0.62) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL933349 | 0.79 | CYP3A4 (0.62) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL4389588 | 0.79 | CYP1A2 (0.53) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 | |
| SCHEMBL27992715 | 0.79 | CYP1A2 (0.53) | CYP1A2CYP3A4SLC6A3SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3031447-B1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2019-12-25 | — | — | EP | disclosed |
| US-20160184457-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2016-06-30 | — | — | US | disclosed |
| EP-3031447-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | Japan Science and Technology Agency (JP) | 2016-06-15 | — | — | EP | disclosed |
| EP-0786006-B1 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LTD (GB) | 2005-09-28 | — | — | EP | disclosed |
| WO-2002083951-A1 | MULTIPLEXED LIGAND/PROTEIN BINDING ASSAYS WITH PNA LABELS | NORTHEASTERN UNIVERSITY (US) | 2002-10-24 | — | — | WO | disclosed |
| US-6297032-B1 | EXPRESSING ENZYME ASSOCIATED WITH THE DEGRADATION OF PREFERENTIAL ANTIBIOTIC; TRANSFORM AND CULTURE CELLS, RECOVER PREFERENTIAL PROTEIN | GLAXO GROUP LIMITED (GB) | 2001-10-02 | — | — | US | disclosed |
| US-5919648-A | ONE STEP CONVERSION OF CEPHALOSPORIN C OR DERIVATIVE INTO 7-AMINOCEPHALOSPORANIC ACID OR DERIVATIVE USING AMINOHYDROLASE FROM PSUEDOMONAS VESICULARIS B965; FOR CEPHALOTHIN, CEPHALORIDINE, AND CEFUROXIME SYNTHESIS | GLAXO GROUP LIMITED (GB) | 1999-07-06 | — | — | US | disclosed |
| EP-0786006-A2 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LIMITED (GB) | 1997-07-30 | — | — | EP | disclosed |
| WO-1996016174-A2 | CEPHALOSPORIN C AMIDOHYDROLASE, PRODUCTION AND USE | GLAXO GROUP LIMITED (GB) | 1996-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184457-A1 | NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME | POLM, DNA2, POLRMT | CYP1A2 4882/4885CYP3A4 4878/4885SLC6A3 4336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.